High SIRT1 expression is a negative prognosticator in pancreatic ductal adenocarcinoma
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
High SIRT1 expression is a negative prognosticator in pancreatic ductal adenocarcinoma
Authors
Keywords
Pancreatic cancer, HDAC, Sirt1, Biomarker, Pancreatic ductal adenocarcinoma
Journal
BMC CANCER
Volume 13, Issue 1, Pages -
Publisher
Springer Nature
Online
2013-10-02
DOI
10.1186/1471-2407-13-450
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sirtuin-1 Regulates Acinar-to-Ductal Metaplasia and Supports Cancer Cell Viability in Pancreatic Cancer
- (2013) E. Wauters et al. CANCER RESEARCH
- SIRT1 regulates differentiation of mesenchymal stem cells by deacetylating β-catenin
- (2013) Petra Simic et al. EMBO Molecular Medicine
- Activation of p53 by SIRT1 Inhibition Enhances Elimination of CML Leukemia Stem Cells in Combination with Imatinib
- (2012) Ling Li et al. CANCER CELL
- SIRT1 induces EMT by cooperating with EMT transcription factors and enhances prostate cancer cell migration and metastasis
- (2012) V Byles et al. ONCOGENE
- SIRT1 Promotes Tumorigenesis and Resistance to Chemotherapy in Hepatocellular Carcinoma and its Expression Predicts Poor Prognosis
- (2011) Hsieh-Cheng Chen et al. ANNALS OF SURGICAL ONCOLOGY
- p53 Modulates Acquired Resistance to EGFR Inhibitors and Radiation
- (2011) S. Huang et al. CANCER RESEARCH
- SIRT1 RNAi knockdown induces apoptosis and senescence, inhibits invasion and enhances chemosensitivity in pancreatic cancer cells
- (2011) G Zhao et al. GENE THERAPY
- Nicotinamide Phosphoribosyltransferase Is Essential for Interleukin-1β-mediated Dedifferentiation of Articular Chondrocytes via SIRT1 and Extracellular Signal-regulated Kinase (ERK) Complex Signaling
- (2011) Eun-Hee Hong et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Pancreatic cancer
- (2011) Audrey Vincent et al. LANCET
- Restitution of Tumor Suppressor MicroRNAs Using a Systemic Nanovector Inhibits Pancreatic Cancer Growth in Mice
- (2011) D. Pramanik et al. MOLECULAR CANCER THERAPEUTICS
- Regulation of Caenorhabditis elegans lifespan by sir-2.1 transgenes
- (2011) Mohan Viswanathan et al. NATURE
- Absence of effects of Sir2 overexpression on lifespan in C. elegans and Drosophila
- (2011) Camilla Burnett et al. NATURE
- Acetylation-dependent regulation of endothelial Notch signalling by the SIRT1 deacetylase
- (2011) Virginia Guarani et al. NATURE
- Major Molecular Markers in Pancreatic Ductal Adenocarcinoma and Their Roles in Screening, Diagnosis, Prognosis, and Treatment
- (2011) Puneet Singh et al. PANCREAS
- Genomics and pharmacogenomics of pancreatic adenocarcinoma
- (2011) M A Lowery et al. PHARMACOGENOMICS JOURNAL
- Targeting Epigenetic Regulation of miR-34a for Treatment of Pancreatic Cancer by Inhibition of Pancreatic Cancer Stem Cells
- (2011) Dara Nalls et al. PLoS One
- SIRT1 Promotes N-Myc Oncogenesis through a Positive Feedback Loop Involving the Effects of MKP3 and ERK on N-Myc Protein Stability
- (2011) Glenn M. Marshall et al. PLoS Genetics
- SIRT1 Regulates UV-Induced DNA Repair through Deacetylating XPA
- (2010) Wei Fan et al. MOLECULAR CELL
- Sirtuin 1 Modulates Cellular Responses to Hypoxia by Deacetylating Hypoxia-Inducible Factor 1α
- (2010) Ji-Hong Lim et al. MOLECULAR CELL
- Pancreatic Cancer
- (2010) Manuel Hidalgo NEW ENGLAND JOURNAL OF MEDICINE
- Regulation of Hypoxia-Inducible Factor 2 Signaling by the Stress-Responsive Deacetylase Sirtuin 1
- (2009) E. M. Dioum et al. SCIENCE
- PTEN Acetylation Modulates Its Interaction with PDZ Domain
- (2008) T. Ikenoue et al. CANCER RESEARCH
- Deacetylation of cortactin by SIRT1 promotes cell migration
- (2008) Y Zhang et al. ONCOGENE
- The SIRT1 Deacetylase Suppresses Intestinal Tumorigenesis and Colon Cancer Growth
- (2008) Ron Firestein et al. PLoS One
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started